Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04562571
Other study ID # 201701939
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2018
Est. completion date September 30, 2019

Study information

Verified date September 2019
Source Central Hospital, Nancy, France
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a pragmatic, randomised, controlled, before-after interventional study conducted in one region in France in primary care. The GPs in the intervention group will receive a public commitment charter, a non prescription pad and a patient information leaflet to be used when antibiotics are prescribed, while the control group will be not aware of the intervention.


Description:

Antimicrobial resistance is a major public health threat and the overuse of antibiotics contributes to its development.

In France, outpatient antibiotic use remains above the European average. Ninety percent of antibiotics are prescribed to outpatients and 70% of these are prescribed by general practitioners.


Recruitment information / eligibility

Status Completed
Enrollment 349
Est. completion date September 30, 2019
Est. primary completion date September 30, 2019
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- working in the Lorraine region in France

- prescribing more than 25 antibiotic items per 100 patients without a chronic illness, aged 16 to 65 years

- proportion of patients treated with critical antibiotics exceeding 27% (among patients treated with antibiotics)

Exclusion Criteria:

- practicing exclusively alternative medicine, such as homeopathy or acupuncture

- GPs reaching the retirement age in the two years following the beginning of the intervention or who were not working two years before

- GPs who had already displayed a commitment charter promoting antibiotic stewardship in their practice

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Charter & patient information leaflets
Public commitment charter, non-prescription pad, information leaflet in case of antibiotic prescription

Locations

Country Name City State
France Université de Lorraine Nancy Grand Est

Sponsors (2)

Lead Sponsor Collaborator
Central Hospital, Nancy, France University of Lorraine

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Impact of a public commitment charter associated with patient information leaflets on antibiotic's prescription prescription rate by all included GPs of all systemic antibiotics (J01 code according to the Anatomical Therapeutic Chemical - ATC - 2017 classification) between the "before" (2017-2018) and "after" (2018-2019) period using an auto regressive integrated moving average (ARIMA) model 2 years
Secondary Impact of the public commitment charter associated with patient information leaflets on broad-spectrum antibiotics' prescriptions prescription rates by included GPs of amoxicillin-clavulanate (J01CR02), cephalosporins (J01DD) and fluoroquinolones (J01MA) for each eligible GP between the "before" and "after" period using an auto regressive integrated moving average (ARIMA) model 2 years
Secondary Impact of the intervention on the seasonal variation of both total antibiotic use and quinolones' use ratio of the [number of prescriptions of all antibiotics / quinolones during the cold-weather season (January-March and October-December)] / [number of prescriptions of all antibiotics / quinolones during the hot-weather season (April-September)] - 1 x 100 Title: Broad-spectrum antibiotics' prescriptions between the "before" and "after" period using ANOVA models 2 years
Secondary Adherence of GPs regarding the intervention: display of the public commitment charter checking visually, without the GP being informed, during the opening hours of the practice, that the charter is effectively displayed in the waiting room at month 12 1 years
Secondary Adherence of GPs regarding the intervention: use patient information leaflets Estimating the number of patient information leaflets distributed to patients by GPs, from the number of pads ordered from the Regional Health Insurance 1 years
Secondary Acceptability of the intervention by GPs semi-structured individual interviews with a randomised sample of GPs from the intervention group and focus groups or individual interviews with patients of the included GPs, in order to assess their perceptions regarding the intervention 1 years
See also
  Status Clinical Trial Phase
Completed NCT04031443 - Prescription Pattern and Awareness About Antibiotic Prophylaxis and Resistance
Completed NCT05221437 - Management and Outcome of Fever in Children in Europe
Recruiting NCT06036628 - Resistant Bacteria in Children in France